Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences Revenue

Cytek Biosciences had revenue of $53.23M in the quarter ending September 30, 2026, with 1.79% growth. This brings the company's total for the last twelve months to $207.65M, up 5.50% year-over-year. In the year 2025, Cytek Biosciences had annual revenue of $201.49M with 0.52% growth. That makes Cytek Biosciences the 17,226th largest company in the world by revenue and 2,855th in the United States.

• Revenue (ttm): $207.65M
• Revenue Growth: +5.50%
• P/S Ratio: 3.67
• Revenue / Employee: $295,370
• Employees: 703
• Market Cap: 763.78M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 95.25M 47.3%
• EMEA 55.88M 27.7%
• APAC 41.08M 20.4%
• Other 9.28M 4.6%

Fiscal year ended Dec 31, 2025 See the full Cytek Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	201.49M	1.04M	0.52%
Dec 31, 2024	200.45M	7.44M	3.85%
Dec 31, 2023	193.02M	28.98M	17.67%
Dec 31, 2022	164.04M	36.09M	28.20%
Dec 31, 2021	127.95M	35.11M	37.82%
Dec 31, 2020	92.84M	34.96M	60.39%
Dec 31, 2019	57.88M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Nov 4, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error